Volume 49, Issue S1 pp. 9-17
ORIGINAL RESEARCH

In vitro bactericidal efficacy of a new triple antibiotic paste formulation against Enterococcus faecalis biofilm

Benjaporn Smittiset DDS

Benjaporn Smittiset DDS

Department of Operative Dentistry and Endodontics, Faculty of Dentistry, Mahidol University, Bangkok, Thailand

Search for more papers by this author
Danuchit Banomyong DDS, PhD

Danuchit Banomyong DDS, PhD

Department of Operative Dentistry and Endodontics, Faculty of Dentistry, Mahidol University, Bangkok, Thailand

Search for more papers by this author
Nisarat Ruangsawasdi DDS, MSc, PhD

Nisarat Ruangsawasdi DDS, MSc, PhD

Department of Pharmacology, Faculty of Dentistry, Mahidol University, Bangkok, Thailand

Search for more papers by this author
Jittranan Kaewprag DDS, PhD

Corresponding Author

Jittranan Kaewprag DDS, PhD

Department of Operative Dentistry and Endodontics, Faculty of Dentistry, Mahidol University, Bangkok, Thailand

Correspondence

Jittranan Kaewprag, Department of Operative Dentistry and Endodontics, Faculty of Dentistry, Mahidol University, Yothi Road, Bangkok 10400, Thailand.

Email: [email protected]

Search for more papers by this author
First published: 08 September 2022

Abstract

The aim of this study was to evaluate the bactericidal efficacy on Enterococcus faecalis biofilm of a novel, low-concentration triple-antibiotic paste (TAP-L2) in propylene glycol/carboxymethylcellulose vehicle (VEH-2), a ready-to-use prototype, compared with two currently used products; a low-concentration (TAP-L1) and a high-concentration paste (TAP-H1) mixed in macrogol/propylene glycol vehicle (VEH-1). Sixty-two root canals were infected with E. faecalis biofilm, medicated with (a) TAP-L1, (b) TAP-L2, (c) TAP-H1, (d) VEH-1 or (e) VEH-2 (n = 10) and incubated for 21 days. Live/dead assays were performed using confocal laser scanning microscopy (CLSM), and dead bacteria (%) were calculated. The TAP-H1 group demonstrated the highest dead bacteria (67.54 ± 2.38%), which was significantly higher than the TAP-L2 and TAP-L1 groups (56.85 ± 7.11% and 54.23 ± 10.19%) (p < 0.05). The TAP groups demonstrated significantly higher dead bacteria than the VEH-1 and VEH-2 groups (47.51 ± 6.41% and 45.14 ± 8.28%) (p < 0.05). The ready-to-use TAP-L2 had antibacterial activity comparable to TAP-L1, both of which were lower than TAP-H1.

CONFLICT OF INTEREST

The authors declare that they have no conflicts of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.